The FDA today issued a notice labeling the recall of Boston Scientific Accolade pacemaker devices serious as it may cause ...

Boston Scientific Corp. grew its headcount by 5,000 and its real estate footprint by more than 1 million square feet in 2024.

Boston Scientific Corporation BSX, despite industrywide macroeconomic upheavals, has been seeing strong growth momentum ...

Boston Scientific announced won CE mark for its navigation-enabled Farawave Nav ablation catheter and Faraview software.

Argus raised the firm’s price target on Boston Scientific (BSX) to $130 from $105 and keeps a Buy rating on the shares. The firm sees strong ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target ...

For instance, the price of Boston Scientific Corporation (NYSE:BSX) stock is up an impressive 143% over the last five years. Also pleasing for shareholders was the 20% gain in the last three months.

The tools ideate on Boston Scientific’s Farapulse PFA system, which contributed towards a 172% uptick in the company’s Q4 ...

In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other best fundamental stocks to buy now. The S&P 500 index closed 0.3% lower at 6,101 ...

The question was meant as a moment of levity, but it cut to the trepidation of scientific communities across the nation in the early days of President Trump’s new administration. “Is anyone ...

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and ...